SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia-Reference-Cited by-同舟云学术

SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia

Published:2014-03-03 Issue:4 Volume:165 Page:504-509
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Advani Anjali S.¹,McDonough Shannon²,Coutre Steven³,Wood Brent⁴,Radich Jerald⁵,Mims Martha⁶,O'Donnell Margaret⁷,Elkins Stephanie⁸,Becker Michael⁹,Othus Megan²,Appelbaum Frederick R.⁵

Affiliation:

1. Hematologic Oncology and Blood Disorders; Taussig Cancer Institute; The Cleveland Clinic; Cleveland OH USA

2. SWOG Statistical Center; Fred Hutchinson Cancer Center; Seattle WA USA

3. Stanford University School of Medicine; Stanford CA USA

4. Seattle Cancer Care Alliance; Seattle WA USA

5. Fred Hutchinson Cancer Research Center; Seattle WA USA

6. Baylor Medical Center; Houston TX USA

7. City of Hope National Medical Center; Duarte CA USA

8. University of Mississippi; Jackson MS USA

9. University of Rochester Medical Center; Rochester NY USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12778/fullpdf

Reference12 articles.

1. Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia;Advani;British Journal of Haematology,2010

2. Expression and structure of CD22 in acute leukaemia;Boue;Blood,1988

3. Outcome of 609 adults after relapse of acute lymphoblastic leukaemia (ALL); an MRC UKALL12/ECOG 2993 study;Fielding;Blood,2007

4. Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukaemia cells in vitro;Herrera;Leukaemia,2000

5. High-dose chemotherapy in adult acute lymphoblastic leukaemia;Hoelzer;Seminars in Hematology,1991

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia;Oncogene;2023-11-29

2. A systematic review on the cost-effectiveness assessment of tisagenlecleucel for refractory or relapsing B-cell acute lymphoblastic leukemia (R/R B-ALL) treatment in children and young adults;Cytotherapy;2023-09

3. Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy;Cytometry Part B: Clinical Cytometry;2023-01-22

4. Changing Landscape in the Treatment of Adult Acute Lymphoblastic Leukemia (ALL);Cancers;2022-09-01

5. Monoclonal antibodies for the treatment of acute lymphocytic leukemia: A literature review;Human Antibodies;2022-08-26